Pfizer’s Blockbuster Migraine Portfolio Plan On Track With Zavzpret Approval

Second Product From $11.6bn Biohaven Acquisition

 
• By Mandy Jackson
  
Woman having headache, migraine. Cartoon vector illustration.
Zavzpret provided rapid pain and symptom relief in its Phase III trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip